Seneca study

Radical Hysterectomy Selective Systematic Nerve-Sparing C2, unedited 4K youtu.be/33bru8YADyk?si… “The ability to perform radical hysterectomy with precision, reflects a surgeon’s advanced command of pelvic anatomy and surgical expertise — excellence in pelvic surgery.” @IJGConline

🚨 New episode of #IJGCconversations is out! Félix Boria @BoriaFelix dives into the key risk factor for unsuccessful #SLN mapping. Tune in to stay updated on the latest in #GynOnc 🎧 bit.ly/4jkbb24 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_

Sentinel #SENECA risk factors for unsuccessful bi-lateral SLN mapping in #endometrialcancer @BoriaFelix 📌 bit.ly/3SLqR3C @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_

The Surgical Mentorship Webinar on Vulvectomy and Reconstructive Procedures After Radical Surgery is now live on eAcademy! Watch now for expert insights and techniques.

👀👀Regarding BMI, we didn’t find any association with detection rate… Neither as a continuous variable nor as a dichotomous one (30,35 or 40)

👀A lot of heterogeneity can be observed in the surgical technique (site of injection, volume, tracer concentration…) between centers… But, interestingly, NO ❌ differences observed in detection rates in any of these parameters‼️‼️

2139 patients with EC. Bilateral detection rate 82.3%. More than 20 surgical variables analyzed. 5 Risk factors -Modifiable: 👉🏻Open approach 👉🏻Non ICG tracer 👉🏻Low volume surgeon (<20sln/year) -Non modifiable: ❌High grade and >50%myo inv #surgery #endometrialcancer @me4_so

@BoriaFelix @Quique_ChC @lchiv4 @ClinicaNavarra @ESGO_society @ENYGO_official

🚨🚨🚨Already available online our last article: Sentinel SENECA. We evaluated risk factors for unsuccessful bilateral SLN in more than 2000 patients!!! Take a look👇🏻👇🏻👇🏻 …l-journal-of-gynecological-cancer.com/article/S1048-…

Results of the SUROVA study are coming out in less than 2 hours!!!😱😱😱 We look forward to seeing you in Session Hall 1 to share with you new evidence in advanced ovarian cancer surgery! 🔪🔪🔪 Stay tuned!!! 🎯🎯🎯 #esgo2025 @lchiv4 @ClinicaNavarra

Vuelve la VI Edición del Curso de Cirugía Ginecológica Avanzada! Dos jornadas intensivas con práctica en modelo “cadáver en fresco y porcino", en un entorno único,@ClinicaNavarra🏥 Aprende de grandes expertos @lchiv4🔝 y perfecciona tus habilidades quirúrgicas🔪 Inscríbete ya!🎯

The Spanish Congress of Gynecology Oncology has just concluded. We were able to present two sub-analyses of the SENECA study and the validation our predictive index for complete cytoreduction in advanced ovarian cancer… A lot of science and friends… we keep going! @Onco_SEGO

#SENECAstudy #IJGCclub

Incredible discussion today!🤩 Huge thanks to the @SENECAStudy team and @Quique_ChC for the amazing results, and to our attendees and societies @ESGO_society and @IGCSociety A fantastic first #IJGCclub for our @IJGCfellows! See you in October! 🎉 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Jc_vilches @erodriguezglez @daggezmine @astraubhar @raikhanbo

See you in 30 mins 🕒 It's almost time! Join us in 30 mins for our #IJGCclub! 📚✨ Don't miss out on this exciting discussion with @Quique_ChC on the @SENECAStudy 👉 Staging endometrial cancer based on molecular classification See you soon! Zoom link 💻 bit.ly/47E3jEn @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @Frumovitz @HousseinELHAJJ3 @AinhoaMada @Jc_vilches @erodriguezglez @daggezmine @astraubhar #WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

📣 📣 📣 Join us #IJGCclub 📆Sept 24 ⏰11am CDT/6pm CET @Quique_ChC will be discussing about the @SENECAStudy 👉 Staging endometrial cancer based on molecular classification 💻 bit.ly/47E3jEn @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Jc_vilches @erodriguezglez @daggezmine @astraubhar @raikhanbo

📣 📣 📣 Join us #IJGCclub 📆Sept 24 ⏰11am CDT/6pm CET @Quique_ChC will be discussing about the @SENECAStudy 👉 Staging endometrial cancer based on molecular classification @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Jc_vilches @erodriguezglez @daggezmine @astraubhar @raikhanbo

#Editorial on #SENECA study @SENECAStudy @ bit.ly/3MA71Fm #SLNmapping #EndometrialCancer @Quique_ChC @ClinicaNavarra @JennyMueller @Doctor_Beryl @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @Frumovitz @HousseinELHAJJ3 @AinhoaMada @Jc_vilches @erodriguezglez @daggezmine @astraubhar #WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

@ClinicaNavarra @lchiv4 Check out our podcast! x.com/IJGConline/sta…

Our SENECA study has just been published! I am honoured to have led this ambitious project with more than 2000 patients from more than 60 centres all over the world! Thank you all for your collaboration! Together further! @ClinicaNavarra @lchiv4 x.com/IJGConline/sta…